| Alfred Benjamin Cheng, MD | |
|
1 Cooper Plz, Camden, NJ 08103 | |
| (856) 342-2351 | |
| Not Available |
| Full Name | Alfred Benjamin Cheng |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 18 Years |
| Location | 1 Cooper Plz, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124266507 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD439473 (Pennsylvania) | Secondary |
| 207P00000X | Emergency Medicine | 25MA09557500 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cooper Urgent Care Pc | 2860644234 | 54 |
| Cooper Univeristy Emergency Physicians Pc | 4486627551 | 60 |
News Archive
Emergent BioSolutions Inc. today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to advance the development of MVA85A, a candidate vaccine against tuberculosis.
BioBehavioral Diagnostics (BioBDx), a privately held company which manufactures and markets the Quotient™ ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today the first close of a $10 million Series B financing.
Arcapita, a global investment company, announced today that Atlanta-based CardioMEMS, an Arcapita Ventures portfolio company, has entered into an equity investment and option to purchase agreement with St. Jude Medical, a global medical device company.
A study to be published in the February 2016 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports that adolescents chronically victimized during at least two school years, are about five times more at risk of thinking about suicide and 6 times more at risk of attempting suicide at 15 years compared to those who were never victimized.
Cancers arise in the body all the time. Most are nipped in the bud by the immune response, not least by its T cells, which detect telltale molecular markers-or antigens-on cancer cells and destroy them before they grow into tumors. Cancer cells, for their part, evolve constantly to evade such assassination. Those that succeed become full-blown malignancies. Yet, given the right sort of help, the immune system can destroy even these entrenched tumors.
› Verified 4 days ago
| Entity Name | Cooper Univeristy Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689694473 PECOS PAC ID: 4486627551 Enrollment ID: O20040817000551 |
News Archive
Emergent BioSolutions Inc. today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to advance the development of MVA85A, a candidate vaccine against tuberculosis.
BioBehavioral Diagnostics (BioBDx), a privately held company which manufactures and markets the Quotient™ ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today the first close of a $10 million Series B financing.
Arcapita, a global investment company, announced today that Atlanta-based CardioMEMS, an Arcapita Ventures portfolio company, has entered into an equity investment and option to purchase agreement with St. Jude Medical, a global medical device company.
A study to be published in the February 2016 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports that adolescents chronically victimized during at least two school years, are about five times more at risk of thinking about suicide and 6 times more at risk of attempting suicide at 15 years compared to those who were never victimized.
Cancers arise in the body all the time. Most are nipped in the bud by the immune response, not least by its T cells, which detect telltale molecular markers-or antigens-on cancer cells and destroy them before they grow into tumors. Cancer cells, for their part, evolve constantly to evade such assassination. Those that succeed become full-blown malignancies. Yet, given the right sort of help, the immune system can destroy even these entrenched tumors.
› Verified 4 days ago
| Entity Name | Cooper Urgent Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205197365 PECOS PAC ID: 2860644234 Enrollment ID: O20121211000182 |
News Archive
Emergent BioSolutions Inc. today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to advance the development of MVA85A, a candidate vaccine against tuberculosis.
BioBehavioral Diagnostics (BioBDx), a privately held company which manufactures and markets the Quotient™ ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today the first close of a $10 million Series B financing.
Arcapita, a global investment company, announced today that Atlanta-based CardioMEMS, an Arcapita Ventures portfolio company, has entered into an equity investment and option to purchase agreement with St. Jude Medical, a global medical device company.
A study to be published in the February 2016 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports that adolescents chronically victimized during at least two school years, are about five times more at risk of thinking about suicide and 6 times more at risk of attempting suicide at 15 years compared to those who were never victimized.
Cancers arise in the body all the time. Most are nipped in the bud by the immune response, not least by its T cells, which detect telltale molecular markers-or antigens-on cancer cells and destroy them before they grow into tumors. Cancer cells, for their part, evolve constantly to evade such assassination. Those that succeed become full-blown malignancies. Yet, given the right sort of help, the immune system can destroy even these entrenched tumors.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alfred Benjamin Cheng, MD 1 Federal St # 200, Camden, NJ 08103-1088 Ph: (856) 356-4924 | Alfred Benjamin Cheng, MD 1 Cooper Plz, Camden, NJ 08103 Ph: (856) 342-2351 |
News Archive
Emergent BioSolutions Inc. today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to advance the development of MVA85A, a candidate vaccine against tuberculosis.
BioBehavioral Diagnostics (BioBDx), a privately held company which manufactures and markets the Quotient™ ADHD System, a tool that aids in the objective and accurate assessment of attention-deficit hyperactivity disorder (ADHD), announced today the first close of a $10 million Series B financing.
Arcapita, a global investment company, announced today that Atlanta-based CardioMEMS, an Arcapita Ventures portfolio company, has entered into an equity investment and option to purchase agreement with St. Jude Medical, a global medical device company.
A study to be published in the February 2016 issue of the Journal of the American Academy of Child and Adolescent Psychiatry reports that adolescents chronically victimized during at least two school years, are about five times more at risk of thinking about suicide and 6 times more at risk of attempting suicide at 15 years compared to those who were never victimized.
Cancers arise in the body all the time. Most are nipped in the bud by the immune response, not least by its T cells, which detect telltale molecular markers-or antigens-on cancer cells and destroy them before they grow into tumors. Cancer cells, for their part, evolve constantly to evade such assassination. Those that succeed become full-blown malignancies. Yet, given the right sort of help, the immune system can destroy even these entrenched tumors.
› Verified 4 days ago
Rachel Eisenbrock Chase, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Dr. Elizabeth Ann Thompson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Dr. Lars-kristofer Nelson Peterson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Anthony J Mazzarelli, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Cooper University Emergency Physicians, Camden, NJ 08103 Phone: 856-342-2351 Fax: 856-968-8272 | |
Dr. Evan Phillip Cohen, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Department Of Emergency Medicine, Camden, NJ 08103 Phone: 856-342-2351 | |
Thomas Sewatsky, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2351 | |
Dr. Anil Reddy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 800-826-6737 |